Smith Nicholas Conrad Insider Trading -- Recent SEC Form 4 Transactions
Smith Nicholas Conrad (CIK 2009130) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-05). Recent activity: Buy ANRO (55,000 shares), Buy ANRO (54,375 shares), Buy ANRO (56,455 shares), Sell ANRO (110,830 shares), Buy ANRO (24,056 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Alto Neuroscience, Inc. (ANRO) | PRESIDENT AND CFO | Buy | 55,000 | $127,600 |
| 2026-10-01 | Alto Neuroscience, Inc. (ANRO) | PRESIDENT AND CFO | Buy | 54,375 | $127,781 |
| 2026-10-01 | Alto Neuroscience, Inc. (ANRO) | PRESIDENT AND CFO | Buy | 56,455 | $132,669 |
| 2026-10-01 | Alto Neuroscience, Inc. (ANRO) | PRESIDENT AND CFO | Sell | 110,830 | $2.9M |
| 2026-10-01 | Alto Neuroscience, Inc. (ANRO) | PRESIDENT AND CFO | Buy | 24,056 | $56,532 |
| 2026-10-01 | Alto Neuroscience, Inc. (ANRO) | PRESIDENT AND CFO | Sell | 23,170 | $597,290 |
| 2026-10-01 | Alto Neuroscience, Inc. (ANRO) | PRESIDENT AND CFO | Sell | 886 | $23,807 |
| 2026-03-03 | Alto Neuroscience, Inc. (ANRO) | CHIEF FINANCIAL OFFICER & CBO | Sell | 2,806 | $55,250 |
Source: SEC Form 4 filings · as of 2026-10-05